Open AccessFirst-Line Treatment for Patients With Advanced Renal Cell Carcinoma
Author(s) -
Dibash Kumar Das
Publication year - 2021
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000798096.04824.89
Subject(s) - medicine , pembrolizumab , lenvatinib , renal cell carcinoma , kidney cancer , cancer , oncology , malignancy , immunotherapy , thyroid cancer